Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-027354

CHIEF OPERATING OFFICER sold 17,000 shares at $21.04 ($357,680)

  • CHIEF OPERATING OFFICER acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Tessari Eben CHIEF OPERATING OFFICER 2024-11-18 Option exercise 10b5-1 +10,000 $1.59 $15,900 119,975 D: show line 1 in the form
Tessari Eben CHIEF OPERATING OFFICER 2024-11-18 Sale 10b5-1 −17,000 $21.04 $357,680 102,975 D: show line 2 in the form
Open-market sales · 17,000 sh · avg $21.04 · $357,680

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Tessari Eben CHIEF OPERATING OFFICER 2024-11-18 Option exercise · Share Option 10b5-1 −10,000 16,017 D: show line 3 in the form
Loading xslF345X05/form4-11202024_091114.xml…